Green tea polyphenol (-)-epigallocatechin-3-gallate restores Nrf2 activity and ameliorates crescentic glomerulonephritis.

Crescentic glomerulonephritis (GN) is the most severe form of GN and is associated with significant morbidity and mortality despite aggressive immunotherapy with steroids, cytotoxic drugs, and plasmapheresis. We examined the therapeutic efficacy of the green tea polyphenol (-)-epigallocatechin-3-gal...

Full description

Bibliographic Details
Main Authors: Ting Ye, Junhui Zhen, Yong Du, Jason K Zhou, Ai Peng, Nosratola D Vaziri, Chandra Mohan, Yan Xu, Xin J Zhou
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4364748?pdf=render
_version_ 1819051021861650432
author Ting Ye
Junhui Zhen
Yong Du
Jason K Zhou
Ai Peng
Nosratola D Vaziri
Chandra Mohan
Yan Xu
Xin J Zhou
author_facet Ting Ye
Junhui Zhen
Yong Du
Jason K Zhou
Ai Peng
Nosratola D Vaziri
Chandra Mohan
Yan Xu
Xin J Zhou
author_sort Ting Ye
collection DOAJ
description Crescentic glomerulonephritis (GN) is the most severe form of GN and is associated with significant morbidity and mortality despite aggressive immunotherapy with steroids, cytotoxic drugs, and plasmapheresis. We examined the therapeutic efficacy of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG, 50 mg/kg BW/day x3 weeks), a potent anti-inflammatory and anti-oxidant agent, on experimental crescentic GN induced in 129/svJ mice by administration of rabbit anti-mouse glomerular basement membrane sera. Routine histology and key molecules involved in inflammatory and redox signaling were studied. EGCG treatment significantly reduced mortality, decreased proteinuria and serum creatinine, and markedly improved renal histology when compared with vehicle-treated mice. The improvements in renal function and histology were accompanied by the restoration of Nrf2 signaling (which was impaired in vehicle-treated mice) as shown by increased nuclear translocation of Nrf2 and cytoplasmic glutamate cysteine ligase catalytic subunit, glutamate cysteine ligase modifier subunit, and glutathione peroxidase. EGCG-treated mice also showed reduction in p-Akt, p-JNK, p-ERK1/2 and p-P38 as well as restoration of PPARγ and SIRT1 levels. Lower dose of EGCG (25 mg/kg BW/day x2 weeks) treatment also significantly decreased proteinuria and serum creatinine, and markedly improved renal histology when compared with vehicle-treated mice. Thus, our data illustrate the efficacy of EGCG in reversing the progression of crescentic GN in mice by targeting multiple signaling and inflammatory pathways as well as countering oxidative stress.
first_indexed 2024-12-21T11:57:19Z
format Article
id doaj.art-38443ef158ad4f328e8c904e3046ca1a
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T11:57:19Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-38443ef158ad4f328e8c904e3046ca1a2022-12-21T19:04:55ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01103e011954310.1371/journal.pone.0119543Green tea polyphenol (-)-epigallocatechin-3-gallate restores Nrf2 activity and ameliorates crescentic glomerulonephritis.Ting YeJunhui ZhenYong DuJason K ZhouAi PengNosratola D VaziriChandra MohanYan XuXin J ZhouCrescentic glomerulonephritis (GN) is the most severe form of GN and is associated with significant morbidity and mortality despite aggressive immunotherapy with steroids, cytotoxic drugs, and plasmapheresis. We examined the therapeutic efficacy of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG, 50 mg/kg BW/day x3 weeks), a potent anti-inflammatory and anti-oxidant agent, on experimental crescentic GN induced in 129/svJ mice by administration of rabbit anti-mouse glomerular basement membrane sera. Routine histology and key molecules involved in inflammatory and redox signaling were studied. EGCG treatment significantly reduced mortality, decreased proteinuria and serum creatinine, and markedly improved renal histology when compared with vehicle-treated mice. The improvements in renal function and histology were accompanied by the restoration of Nrf2 signaling (which was impaired in vehicle-treated mice) as shown by increased nuclear translocation of Nrf2 and cytoplasmic glutamate cysteine ligase catalytic subunit, glutamate cysteine ligase modifier subunit, and glutathione peroxidase. EGCG-treated mice also showed reduction in p-Akt, p-JNK, p-ERK1/2 and p-P38 as well as restoration of PPARγ and SIRT1 levels. Lower dose of EGCG (25 mg/kg BW/day x2 weeks) treatment also significantly decreased proteinuria and serum creatinine, and markedly improved renal histology when compared with vehicle-treated mice. Thus, our data illustrate the efficacy of EGCG in reversing the progression of crescentic GN in mice by targeting multiple signaling and inflammatory pathways as well as countering oxidative stress.http://europepmc.org/articles/PMC4364748?pdf=render
spellingShingle Ting Ye
Junhui Zhen
Yong Du
Jason K Zhou
Ai Peng
Nosratola D Vaziri
Chandra Mohan
Yan Xu
Xin J Zhou
Green tea polyphenol (-)-epigallocatechin-3-gallate restores Nrf2 activity and ameliorates crescentic glomerulonephritis.
PLoS ONE
title Green tea polyphenol (-)-epigallocatechin-3-gallate restores Nrf2 activity and ameliorates crescentic glomerulonephritis.
title_full Green tea polyphenol (-)-epigallocatechin-3-gallate restores Nrf2 activity and ameliorates crescentic glomerulonephritis.
title_fullStr Green tea polyphenol (-)-epigallocatechin-3-gallate restores Nrf2 activity and ameliorates crescentic glomerulonephritis.
title_full_unstemmed Green tea polyphenol (-)-epigallocatechin-3-gallate restores Nrf2 activity and ameliorates crescentic glomerulonephritis.
title_short Green tea polyphenol (-)-epigallocatechin-3-gallate restores Nrf2 activity and ameliorates crescentic glomerulonephritis.
title_sort green tea polyphenol epigallocatechin 3 gallate restores nrf2 activity and ameliorates crescentic glomerulonephritis
url http://europepmc.org/articles/PMC4364748?pdf=render
work_keys_str_mv AT tingye greenteapolyphenolepigallocatechin3gallaterestoresnrf2activityandamelioratescrescenticglomerulonephritis
AT junhuizhen greenteapolyphenolepigallocatechin3gallaterestoresnrf2activityandamelioratescrescenticglomerulonephritis
AT yongdu greenteapolyphenolepigallocatechin3gallaterestoresnrf2activityandamelioratescrescenticglomerulonephritis
AT jasonkzhou greenteapolyphenolepigallocatechin3gallaterestoresnrf2activityandamelioratescrescenticglomerulonephritis
AT aipeng greenteapolyphenolepigallocatechin3gallaterestoresnrf2activityandamelioratescrescenticglomerulonephritis
AT nosratoladvaziri greenteapolyphenolepigallocatechin3gallaterestoresnrf2activityandamelioratescrescenticglomerulonephritis
AT chandramohan greenteapolyphenolepigallocatechin3gallaterestoresnrf2activityandamelioratescrescenticglomerulonephritis
AT yanxu greenteapolyphenolepigallocatechin3gallaterestoresnrf2activityandamelioratescrescenticglomerulonephritis
AT xinjzhou greenteapolyphenolepigallocatechin3gallaterestoresnrf2activityandamelioratescrescenticglomerulonephritis